Details of the Drug | DrugMAP

General Information of Drug (ID: DMB4OFL)

Drug Name

Darinaparsin

Synonyms

ZIO-101

Indication

Disease Entry	ICD 11	Status	REF
Hematologic tumour	2B33.Y	Phase 2	[1]
Liver cancer	2C12	Phase 2	[1]
Multiple myeloma	2A83	Phase 2	[1]
Peripheral T-cell lymphoma	2A90.C	Phase 2	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C12H22AsN3O6S
Canonical SMILES: C[As](C)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N
InChI: 1S/C12H22AsN3O6S/c1-13(2)23-6-8(11(20)15-5-10(18)19)16-9(17)4-3-7(14)12(21)22/h7-8H,3-6,14H2,1-2H3,(H,15,20)(H,16,17)(H,18,19)(H,21,22)/t7-,8-/m0/s1
InChIKey: JGDXFQORBMPJGR-YUMQZZPRSA-N

Cross-matching ID

PubChem CID: 11683005
ChEBI ID: CHEBI:94295
CAS Number: 69819-86-9
TTD ID: D03ZME

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT00421213) Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)